Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
225 studies found for:    abacavir OR Abacavir/ Lamivudina/ Zidovudina [TREATMENT] AND HIV [CONDITION]
Show Display Options
Rank Status Study
1 Completed Determining the Effect of Abacavir on Platelet Activation
Conditions: HIV;   Cardiovascular Disease
Intervention: Drug: Abacavir
2 Completed
Has Results
PENTA15: Pharmacokinetic Study of Once Versus Twice Daily Abacavir in HIV-1 Infected Children Aged 3 to <36 Months
Condition: HIV Infection
Interventions: Other: Intervention 1: PK assessment while on Twice Daily Abacavir;   Other: Intervention 2: PK assessment while on Once Daily Abacavir
3 Completed Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects
Condition: Healthy Volunteers
Interventions: Drug: Abacavir/Lamivudine;   Drug: Lersivirine
4 Completed Multicentre Study To Assess Changes In Bone Mineral Density Of The Switch From Tenofovir To Abacavir In Hiv-1-Infected Subjects With Loss Of Bone Mineral Density
Condition: HIV
Intervention: Drug: Switch from tenofovir to abacavir
5 Active, not recruiting Tenofovir Abacavir Platelet Activation Study
Condition: HIV
Interventions: Drug: abacavir (600 mg QD);   Drug: tenofovir (245 mg QD)
6 Completed Abacavir Pharmacokinetic Study in the Absence/Presence of Darunavir/Ritonavir or Raltegravir in HIV-infected Subjects
Condition: HIV
Interventions: Drug: Abacavir;   Drug: Darunavir/ritonavir;   Drug: Raltegravir
7 Completed ZIAGEN® Post-marketing Surveillance
Condition: Infection, Human Immunodeficiency Virus I
Intervention: Drug: ZIAGEN®
8 Completed Bioequivalence and Pharmacokinetic Study of Prurisol™ and Abacavir Sulfate in Healthy Volunteers
Condition: Psoriasis
Interventions: Drug: Prurisol;   Drug: Ziagen
9 Completed Abacavir and Lamivudine PK in Children
Condition: HIV
Interventions: Drug: abacavir;   Drug: 3TC
10 Completed
Has Results
Drug Interaction Study With Ribavirin and Abacavir in Male Subjects With Hepatitis C Who Have Failed Ribavirin Treatment
Conditions: Hepatitis C;   HIV
Interventions: Drug: Ribavirin;   Drug: Ribavirin plus Abacavir (ABC)
11 Completed Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily
Condition: HIV Infections
Interventions: Drug: efavirenz;   Drug: Abacavir+lamivudine
12 Active, not recruiting SSAT064: Pharmacokinetics of Abacavir/Lamivudine/Dolutegravir in HIV Patients of 60 Years and Over
Condition: HIV
Intervention: Drug: Triumeq
13 Recruiting Switching From Tenofovir Disoproxil Fumarate to Abacavir or Tenofovir Alafenamide
Conditions: Renal Insufficiency,Chronic;   Hiv;   Therapeutic Agent Toxicity
Interventions: Drug: tenofovir alafenamide;   Drug: abacavir
14 Completed Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected Subjects
Condition: HIV Infection
Intervention: Drug: abacavir
15 Completed Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents
Condition: HIV Infections
Intervention: Drug: Abacavir sulfate
16 Completed Multicentric Open-label Study of Switch From Abacavir/Lamivudine Fixed Dose Combination Plus Nevirapine to Abacavir/Lamivudine/Dolutegravir in Virologically Suppressed HIV-1 Infected Adults (SWAD)
Condition: HIV-1 Infection
Intervention: Drug: Abacavir/Lamivudine/Dolutegravir
17 Completed Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir Hypersensitivity
Condition: HIV Infection
Intervention: Drug: Abacavir
18 Completed Viral Dynamics and Pharmacokinetics of Abacavir and Tenofovir
Condition: HIV Infections
Interventions: Drug: Tenofovir;   Drug: Abacavir
19 Not yet recruiting Triumeq As an Integrase Single Tablet Regimen in People With HIV Who Inject Drugs
Condition: Human Immunodeficiency Virus
Intervention: Drug: dolutegravir/abacavir/lamivudine
20 Completed Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir 50 mg/abacavir 600 mg/lamivudine 300 mg;   Drug: Dolutegravir 50 mg;   Drug: abacavir 600 mg/lamivudine 300 mg

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.